Inovio Pharmaceuticals, Inc. INO saw a big move last session, as the company's shares fell by over 13% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for INO as the stock is now up around 7.6% in the past one-month time frame.
This slump shouldn't be too much of a surprise to investors, as Inovio Pharmaceuticals has seen 2 negative revisions in the past few weeks and its current year consensus loss estimates have widened over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.
INO currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Some better-ranked stocks in the pharmaceutical industry include ANI Pharmaceuticals, Inc. ANIP, Gilead Sciences Inc. GILD and Illumina Inc. ILMN. All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
INOVIO PHARMAC INO: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Market News and Data brought to you by Benzinga APIsThis slump shouldn't be too much of a surprise to investors, as Inovio Pharmaceuticals has seen 2 negative revisions in the past few weeks and its current year consensus loss estimates have widened over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.
INO currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Some better-ranked stocks in the pharmaceutical industry include ANI Pharmaceuticals, Inc. ANIP, Gilead Sciences Inc. GILD and Illumina Inc. ILMN. All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
INOVIO PHARMAC INO: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
